About lenalidomi de
Immunomodulatory anticancer medicine
Used for
- Multiple myeloma, usually with other medicines
- Certain myelodysplastic syndromes
- Mantle cell lymphoma
- Follicular lymphoma
Usual adult dose
Usually 10–25 mg once daily, depending on condition, combination, and kidney function; specialist-directed.
Common side effects
- Low blood cell counts
- Infections
- Blood clots
- Diarrhea, constipation, or rash
Important warnings
- Can cause severe birth defects; strict pregnancy-prevention controls apply.
- Blood clots may occur, especially with myeloma combination treatment.
- Regular blood counts and kidney-function monitoring are needed.
- Do not donate blood or sperm during treatment and for four weeks afterward.
Pregnancy
Must not be used during pregnancy; even one dose can cause severe birth defects.
Breastfeeding
Breastfeeding is not recommended during treatment.
Interactions
- Medicines that increase clot risk may raise the chance of blood clots.
- Digoxin levels may increase; monitoring may be needed.
- Warfarin effects may change; closer monitoring may be needed.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.